This announcement is a separate document:
国浩律师（杭州）事务所关于江苏诺泰澳赛诺生物制药股份有限公司2023年限制性股票激励计划授予事项的法律意见书
Legal Opinion of Guohao Law Firm (Hangzhou) on the granting of the 2023 Restricted Stock Incentive Plan of Jiangsu Nuotai Aosano Biopharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.